Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | BMY | AMGN | MRNA | GILD |
| Company | Adaptimmune Ther ADR | Bristol-Myers Squibb Company | Amgen Inc | Moderna Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.0500 | 47.39 | 273.45 | 107.43 | 67.47 |
| High | 1.0992 | 47.50 | 274.35 | 108.23 | 67.90 |
| Low | 1.0400 | 44.37 | 267.24 | 103.52 | 65.09 |
| Last | 1.0600 | 44.70 | 269.38 | 106.18 | 65.27 |
| Change | -0.0200 | -4.16 | -3.63 | -2.67 | -1.81 |
| % Change | -1.85% | -8.51% | -1.33% | -2.45% | -2.70% |
| Volume | 565,527 | 45,039,223 | 1,791,991 | 2,794,234 | 15,159,173 |
| 20-Day Average Volume | 1,308,391 | 12,857,191 | 2,149,490 | 3,138,067 | 6,861,119 |
| Previous Close | 1.0800 | 48.86 | 273.01 | 108.85 | 67.08 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2116 | 49.94 | 270.70 | 105.00 | 68.68 |
| 20-Day Raw Stochastic | 24.15% | 3.27% | 31.20% | 48.60% | 2.05% |
| 20-Day Relative Strength | 42.49% | 28.31% | 44.80% | 53.03% | 28.32% |
| Weighted Alpha | -48.69 | -34.75 | +9.12 | -11.43 | -23.73 |
| Today's Opinion | 24% Buy | 88% Sell | 72% Sell | 100% Buy | 100% Sell |
| Previous Opinion | 40% Buy | 88% Sell | 40% Sell | 88% Buy | 100% Sell |
| Last Month's Opinion | 80% Buy | 8% Sell | 24% Buy | 72% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.99% since 04/18/24 | -7.45% since 04/18/24 | +2.52% since 04/18/24 | +4.10% since 04/18/24 | -1.35% since 04/18/24 |
| Low | 0.9200 on 04/19/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 99.30 on 04/22/24 | 65.09 on 04/25/24 |
| High | 1.1600 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 111.29 on 04/24/24 | 67.90 on 04/25/24 |
| 1-Month | |||||
| %Chg | -26.39% since 03/25/24 | -14.45% since 03/25/24 | -4.07% since 03/25/24 | -3.81% since 03/25/24 | -10.07% since 03/25/24 |
| Low | 0.8721 on 04/18/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 97.00 on 04/03/24 | 65.09 on 04/25/24 |
| High | 1.6500 on 03/28/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 115.89 on 04/09/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | +43.83% since 01/25/24 | -9.90% since 01/25/24 | -13.18% since 01/25/24 | +3.28% since 01/25/24 | -18.65% since 01/25/24 |
| Low | 0.7200 on 01/26/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 84.06 on 02/13/24 | 65.09 on 04/25/24 |
| High | 2.0500 on 03/08/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 115.89 on 04/09/24 | 80.51 on 01/26/24 |
| 6-Month | |||||
| %Chg | +78.24% since 10/25/23 | -21.04% since 10/25/23 | -1.02% since 10/25/23 | +38.33% since 10/25/23 | -16.74% since 10/25/23 |
| Low | 0.4200 on 11/28/23 | 44.37 on 04/25/24 | 249.70 on 10/31/23 | 62.55 on 11/02/23 | 65.09 on 04/25/24 |
| High | 2.0500 on 03/08/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 115.97 on 01/08/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,073,750 | 99,027,448 | 146,436,016 | 41,676,488 | 83,519,768 |
| Shares Outstanding, K | 994,213 | 2,026,759 | 536,376 | 382,880 | 1,245,077 |
| Annual Sales | 60,280,000 | 45,006,000,000 | 28,190,000,000 | 6,848,000,000 | 27,116,000,000 |
| Annual Net Income | -113,870,000 | 8,025,000,000 | 6,717,000,000 | -4,714,000,000 | 5,665,000,000 |
| Last Quarter Sales | 230,000 | 11,477,000,000 | 8,196,000,000 | 2,811,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -47,920,000 | 1,762,000,000 | 767,000,000 | 217,000,000 | 1,429,000,000 |
| 60-Month Beta | 2.39 | 0.39 | 0.58 | 1.62 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 03/06/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 0.55 on 02/22/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/10/24 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | N/A | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.53 | 14.67 | 0.00 | 9.97 |